Abstract
The gut microbiome, a complex community of microorganisms residing in the gastrointestinal tract, plays a critical role in maintaining metabolic homeostasis. Recent research has highlighted the link between an imbalance in the gut microbiota, also known as dysbiosis, and the development of metabolic diseases such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease. This article explores the mechanisms through which the gut microbiome influences metabolic health, its involvement in metabolic diseases, and potential therapeutic approaches targeting the microbiome for disease prevention and treatment.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 American Journal of Biological Sciences